Delivery Order SPE2DR25D1106-SPE2DR26FJD2W
Award Date 12/11/25
Potential Completion Date 12/12/25
Potential Value $8.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $19,657.60 delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Actemra 400 mg/20 ml vials. This is a firm fixed-price, competitively awarded contract with a completion date of November 28, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation. This delivery order is a child contract executed under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $39,176.41 delivery order to AmerisourceBergen Drug Corp for the supply of Actemra 400 mg/20 mL vials on December 9, 2025, with an ultimate completion date of December 10, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded under open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 12, 2025, for the supply of Actemra 162 mg/0.9 mL syringes valued at $4,594.53. This firm fixed-price, competitively awarded delivery order is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency, and has an ultimate completion date of August 13, 2025. The award was made under no set-aside designation,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency valued at $4,894.92 for Actemra 162 mg/0.9 mL syringes. The contract is a firm fixed price delivery order with an ultimate completion date of June 18, 2025, and represents a non-set-aside competitive award. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Actemra 400 mg/20 mL vials with a ceiling value of $6,630.33. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with an ultimate completion date of June 3, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $11,196.02 to AmerisourceBergen Drug Corp for 4,568,895,450 units of Actemra 400 mg/20 mL vials on July 25, 2025, with an ultimate completion date of July 28, 2025. The contract utilizes firm fixed pricing with no set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a competitive award under AmerisourceBergen's existing Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,736.36 for Actemra 162 mg/0.9 mL syringes on December 9, 2025, with completion scheduled for December 10, 2025. This firm fixed-price contract, which was not set aside for any socioeconomic category, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $2,411.08 by the Defense Logistics Agency (DLA) for Actemra 162 mg/0.9 ml syringes. The contract represents a firm fixed price delivery order with an ultimate completion date of December 8, 2025, and was competitively awarded without set-aside provisions. This award falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 22, 2025, for the supply of Actemra 162 mg/0.9 mL syringes with a ceiling value of $4,616.50. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract calls for delivery to the company's headquarters in Conshohocken, Pennsylvania, with an ultimate completion date of September 23, 2025. This award is a child contract...
- The Defense Logistics Agency awarded a $20,188.75 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Actemra 400 mg/20 ml vials. This is a firm fixed price, non-set-aside contract with a completion date of September 22, 2025, and performance occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX),...